Analysis of thiopurine methyltransferase variant alleles in childhood acute lymphoblastic leukaemia

Howard L. McLeod(Central South University), Brenda Gibson(Royal Hospital for Children), O. B. Eden(Royal Manchester Children's Hospital), Sally A. Coulthard(Newcastle University), Andrew G. Hall, Susan Richards(MRC Clinical Trials Unit at UCL), Angela Thomas(Royal Hospital for Children), Derek J. King(Aberdeen Royal Infirmary), Stuart C. Pritchard(University of Aberdeen)

British Journal of Haematology

June 1, 1999

10.1046/j.1365-2141.1999.01416.x

Cited by 128

Related Papers

Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study

|Blood|2006|843

In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993)

|Blood|2007|782

Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel

|Blood|2012|575

Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism

|Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease|2002|430

Optimization of Chemotherapy for Younger Patients With Acute Myeloid Leukemia: Results of the Medical Research Council AML15 Trial

|Journal of Clinical Oncology|2013|415